Fatemeh Rahbarizadeh

10PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomaterialsAgricultural molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 15, 2026
EF-1α-driven nanobody-based CD19-redirected CAR-T cells retain the antitumor efficacy, antigen-driven expansion, and cytokine secretion of CMV-driven counterparts.

|Aug 23, 2022
Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library.

Nasir Shams, Shahryar Khoshtinat Nikkhoi, Zhanjun Gu

|Jul 11, 2022
Eco-friendly synthesis of carbon nanotubes and their cancer theranostic applications.

Ebrahim Mostafavi, Siavash Iravani, Rajender S Varma

|Dec 27, 2021
Addressing the obstacles of CAR T cell migration in solid tumors: wishing a heavy traffic.

Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani, Fatemeh Rahbarizadeh

|Dec 03, 2021
A brief review on DNA vaccines in the era of COVID-19.

Maryam Shafaati, Massoud Saidijam, Meysam Soleimani

|Oct 08, 2021
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh

Pageof 2

Frequent Collaborators

2 joint publications

Cobra Moradian

2 joint publications

Pooria Safarzadeh Kozani

1 joint publications

Saeed Ranjbar

1 joint publications

Maryam Shafaati